4th Quarter - Report

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS for AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Firm
Client
Income
—
Expenses
$19,972
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Education EDU

ExCEL Act (HR 1716)

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1716 (113th)

Medicare/Medicaid MMM

Protecting Seniors' Access to Medicare Act (HR 351/S 351) Medicare Physician Reimbursement Reform Medicare Patient Access and Quality Improvement Act (HR 2810) SGR Repeal and Medicare Beneficiary Access Act (S 1871) SGR Repeal and Medicare Provider Payment Modernization Act (HR 4015/S 2000) Protecting Access to Medicare Act (HR 4302) Prohibiting discrimination based on a health care providers degree

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2810 (113th), H.R. 4302 (113th), H.R. 4015 (113th), H.R. 351 (113th)

Alcohol and Drug Abuse ALC

Safe Prescribing Act (HR 1285/S 621) Stop Oxy Abuse Act (HR 1366) Prescription Drug Abuse Prevention and Treatment Act (HR 672/S 348) Access to Substance Abuse Treatment Act of 2013 (HR 2130) Reclassification of hydrocodone-containing combination drug products Innovative packaging, storage, and disposal systems, technologies or designs that could be used to prevent or deter misuse and abuse of opioid analgesics

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA)

Bills named: H.R. 1366 (113th), H.R. 672 (113th), H.R. 2130 (113th), H.R. 1285 (113th)

Taxation/Internal Revenue Code TAX

Protect Medical Innovation Act (HR 523) Medical Device Access and Innovation Protection Act (S 232)

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 523 (113th)

Health Issues HCR

Family Health Care Flexibility Act (HR 1248/S 610) Prevention of Prescription Drug Shortages Coordination of Pro Bono Medically Recommended Dental Care Act (HR 963/S 466) Action for Dental Health Act (HR 4395)

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 963 (113th), H.R. 1248 (113th), H.R. 4395 (113th)

Budget/Appropriations BUD

FY2015 Labor-HHS-Education appropriations legislation that restores funding for the National Institutes of Health (NIH) to, at a minimum, pre-sequestration levels.

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Insurance INS

Competitive Health Insurance Reform Act (HR 911) Dental Insurance Fairness Act (HR 1798)

LobbyistCovered position, as disclosed
ADAM BRENMAN —
SANDRA MARIE GUENTHER —
JEANNE TUERK —
KARIN WITTICH —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1798 (113th), H.R. 911 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.